Introduction: The study aimed to compare the incidence of cardiovascular events (CVEs) after donor nephrectomy (DN) and radical tumor nephrectomy (RN), according to an estimated glomerular filtration rate (eGFR), were evaluated over time. Materials and Methods: Follow-up was collected for DN who underwent surgery from 1998 to 2007 for CVE and renal function. All DN were matched for age to patients treated by RN or adenoma enucleation (control group), who were eligible for DN. eGFR was estimated using the Cockgroft-Gould formula. Patients with preoperative comorbidities were excluded. Results: Thirty DN (median age 48.9 years) were included with a median follow-up of 138.5 months (interquartile range 119-159). No significant differences in patients' characteristics were found preoperatively (p > 0.5). Four out of 30 DN developed a CVE (3 myocardial infarctions (MI), 1 stroke), 2 of 30 patients in the control group (both MI) and 8 of 30 RN patients (6 MI, 2 strokes, p > 0.05). Arterial hypertension developed in 14 DN (46.7%), in 12 (40%) after RN and in 15 controls. The CVE occurred after a median time of 68 months (5-231) and were related to a drop of ∼30% in the eGFR irrespective of the group. Conclusion: Decline of renal function after nephrectomy is the main risk factor for CVE. Close monitoring of renal function and new onset hypertension is warranted.

1.
Van Poppel H, et al: A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-552.
[PubMed]
2.
Chronic Kidney Disease Prognosis Consortium, Matsushita K, et al: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-2081.
[PubMed]
3.
National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 suppl 1):S1-S266.
[PubMed]
4.
Girndt M, Trocchi P, Scheidt-Nave C, Markau S, Stang A: The prevalence of renal failure - results from the German health interview and examination survey for adults, 2008-2011 (DEGS1). Dtsch Arztebl Int 2016;113:85-91.
[PubMed]
5.
Go AS, et al: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305.
[PubMed]
6.
McKiernan J, et al: Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 2002;59:816-820.
[PubMed]
7.
Sarnak MJ, et al: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 2003;42:1050-1065.
[PubMed]
8.
Huang WC, et al: Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006;7:735-740.
[PubMed]
9.
Segev DL, et al: Perioperative mortality and long-term survival following live kidney donation. JAMA 2010;303:959-966.
[PubMed]
10.
Reese PP, et al: Selecting appropriate controls for kidney donors - reply. Am J Transplant 2015;15:287-288.
[PubMed]
11.
Ibrahim HN, et al: Long-term consequences of kidney donation. N Engl J Med 2009;360:459-469.
[PubMed]
12.
Fehrman-Ekholm I, et al: Kidney donors live longer. Transplantation 1997;64:976-978.
[PubMed]
13.
Okamoto M, et al: The consequences for live kidney donors with preexisting glucose intolerance without diabetic complication: analysis at a single Japanese center. Transplantation 2010;89:1391-1395.
[PubMed]
14.
Garg AX, et al: Cardiovascular disease in kidney donors: matched cohort study. BMJ 2012;344:e1203.
[PubMed]
15.
Mjoen G, et al: Long-term risks for kidney donors. Kidney Int 2014;86:162-167.
[PubMed]
16.
Neuhauser H, Thamm M, Ellert U: Blutdruck in deutschland 2008-2011. Ergebnisse der studie zur gesundheit erwachsener in eutschland (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013;56:795-801.
[PubMed]
17.
Krebs RK, Andreoni C, Ortiz V: Impact of radical and partial nephrectomy on renal function in patients with renal cancer. Urol Int 2014;92:449-454.
[PubMed]
18.
Roos FC, et al: Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cm. Urology 2012;79:607-613.
[PubMed]
19.
Demirjian S, et al: Chronic kidney disease due to surgical removal of nephrons: relative rates of progression and survival. J Urol 2014;192:1057-1062.
[PubMed]
20.
Lorenz MW, et al: Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007;115:459-467.
[PubMed]
You do not currently have access to this content.